Podcasts about epidemiologists

There currently are over 2,000 confirmed cases of measles in the United States of America, including some cases in Connecticut’s surrounding states. Today, we get an update on measles closer to home, and abroad. Plus, we’ll hear about the Ebola outbreak in the Democratic Republic of Congo, and other parts of central Africa. Guests: Dr. Ulysses Wu: Chief Epidemiologist at Hartford Healthcare Dr. David B. Banach: Head of Infection Prevention and Hospital Epidemiologist at UConn Provash Budden: Americares Deputy SVP of Emergency Programs Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.

Day Break | Tulsi Out, Election Results In, and the Fight for America's Health --- 00:00 - Monologue 19:10 – Joe Kent, former Director of the National Counterterrorism Center, Green Beret, and CIA officer. Kent discusses his resignation from the National Counterterrorism Center, responding to reports surrounding his departure and speculation about potential investigations. He also weighs in on U.S. policy toward Iran, Israel, and the broader Middle East, explains why he views border security as a national security issue, and shares his perspective on what he believes is the greatest threat facing America today. 38:08 - Monologue Featuring Ivey Gruber 47:05 – Nicolas Hulscher, MPH, Epidemiologist and Administrator of The McCullough Foundation. Hulscher discusses the recent publication of an observational study examining ivermectin and mebendazole in cancer treatment. He explains the significance of peer-reviewed publication, what observational studies can and cannot demonstrate, how the research may inform future investigations, and where interested individuals can learn more about the topic. 57:19 – Josh Seiter, political satirist and commentator. Seiter discusses the use of satire and comedy to challenge cultural and political narratives, the public backlash against what critics describe as “woke” ideology, and how humor can be used to spark conversation about social and political issues. 1:16:25 - Monologue 1:25:24 – Ron Rademacher, travel writer, author, storyteller, and Michigan backroads expert. Rademacher highlights events taking place across Michigan, including the Mackinac Island Lilac Festival, the Michigan Lavender Festival in Imlay City, the Blue Water Sturgeon Festival in Port Huron, National Donut Day celebrations in Charlevoix, the Lyon Township International Kite Festival, Gizzard Fest in Potterville, and numerous other community events happening throughout the state. He also gives a special mention to his upcoming presentation, Oddities & Rarities, at the Chelsea District Library. 1:35:24 – Perry Johnson, businessman, author, and political candidate from Michigan. Johnson discusses concerns surrounding emerging vehicle technology, including so-called “kill switch” capabilities in modern automobiles, government regulations, privacy issues, and what these technologies could mean for drivers in the future. 1:44:08 – Ivey Gruber, President of the Michigan Talk Network. Gruber discusses a controversial political candidate whose background and associations have drawn scrutiny, along with developments in California's primary elections and what the results may signal about voter attitudes and the state's political future. --- Check out our brand new podcast, 'Forgotten America'... Episode 17 is live NOW at Steve Gruber on YouTube! Link below: https://youtu.be/ULMlE_xv87Q

Dr Funmi Okunola MD interviews Dr Guillaume Dedet MD, MPH, MSc, MA - Senior Health Economist at the Organisation for Economic Co-Operation and Development (OECD) andDr David Kelly MD, MPH, MRCIP, CSCST - Public Health Physician & Epidemiologist at the OECD about their April 2026 report - "Addressing the Costs & Care of Long COVID for Long COVID the Long Shadow of the Pandemic". We also dive into their October 2025 OECD report - "The Prevalence and Impact of Long COVID in the Primary Care Population - Findings from the OECD PaRIS Survey".REFERENCES 1. Addressing the Costs & Care of Long COVID for Long COVID the Long Shadow of the Pandemic. 2. The Prevalence and Impact of Long COVID in the Primary Care Population - Findings from the OECD PaRIS Survey

Africa Melane speaks to Dr Leigh Johnson, an actuary and epidemiologist, based at the Centre for Infectious Disease Epidemiology and Research, at the University of Cape Town, and developer the Thembisa model. They discuss the latest data which shows South Africa’s Hiv programs are slowing down; while the infection rate continues to climb. This follows Hiv program funding cuts by the U.S. Good Morning Cape Town with Lester Kiewit is a podcast of the CapeTalk breakfast show. This programme is your authentic Cape Town wake-up call. Good Morning Cape Town with Lester Kiewit is informative, enlightening and accessible. The team’s ability to spot & share relevant and unusual stories make the programme inclusive and thought-provoking. Don’t miss the popular World View feature at 7:45am daily. Listen out for #LesterInYourLounge which is an outside broadcast – from the home of a listener in a different part of Cape Town - on the first Wednesday of every month. This show introduces you to interesting Capetonians as well as their favourite communities, habits, local personalities and neighbourhood news. Thank you for listening to a podcast from Good Morning Cape Town with Lester Kiewit. Listen live on Primedia+ weekdays between 06:00 and 09:00 (SA Time) to Good Morning CapeTalk with Lester Kiewit broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/xGkqLbT or find all the catch-up podcasts here https://buff.ly/f9Eeb7i Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalkSee omnystudio.com/listener for privacy information.

Dr. Dave Engelthaler joined Bruce & Gaydos to explain what you need to know about the Hantavirus outbreak.

There's confidence from some that the hantavirus outbreak won't turn into another worldwide pandemic. Passengers are being evacuated and returning to home countries, including one New Zealander. Authorities say one of five French passengers developed symptoms flying to Paris, and will isolate until further notice. Otago University epidemiologist, Michael Baker, says person to person transmission is very unusual for this virus. "And when they're investigated, these are often people who are living in the same house or the same bedroom or are spending a lot of time together - it's not from casual contact." LISTEN ABOVESee omnystudio.com/listener for privacy information.

The CNN thunderdome didn't know what to say when they found out the new Congressional seat after Tennessee redistricting will go to a Republican Black woman. Tucker Carlson claims that he told Trump to his face that Netanyahu hates him. Acting Attorney General Todd Blanche pulls out his copy of the Constitution and shows CBS the Constitution gives the president the power to direct the Justice Department. Barack Obama praises Zohran Mamdani. AOC says “Black Americans created democracy”. Rep. Tim Burchett goes on Rogan to discuss the Butler assassination conspiracies, mail-in voting and more. Epidemiologists are calming fears over the hantavirus. Nick Shirley crushes his appearance with Stephen A. Smith. Will the alien files actually be released this weekend? Is it a distraction from Iran?Thank you for supporting our sponsors that make The Dana Show possible…Native Path Grass Fed Collagenhttps://GetNativePath.com/DanaFor my special offer get up to 45% OFF. Try it risk-free with a 365-day money-back guarantee.PreBornhttps://www.PreBorn.com/Dana or #250 AND SAY “BABY”Help Preborn Fund 1,000 ultrasounds by Mother's Day, and protect mothers and babies in crisis. Help us reach our goal!Fresh Pressed Olive Oilhttps://DanaLovesOliveOil.comTry it now and get a full-sized $49 bottle of Fresh Pressed Olive Oil for FREE just pay $1 shipping with no commitment—Claim yours today.Pocket HoseText DANA to 64000For a limited time, get two FREE gifts—a 360° rotating pocket pivot and thumb drive nozzle when you buy a new Pocket Hose Ballistic; just text DANA to 64000, message and data rates may apply.Fast Growing Treeshttp://fastgrowingtrees.com/Dana Get an additional 20% Percent Off Better Plants and Better Growing by using code DANA at checkout. Byrnahttps://Byrna.com/DanaTrusted by law enforcement, security professionals, and everyday Americans—defend yourself and your family with Byrna.HumanNhttps://Humann.com/DanaSupport your heart health with SuperBeets Heart Chews Zero Sugar now Buy 2 get 1 Free. Visit today to learn how to get a Free 30-day supply. Ask ChapterDial #250 and say “My Medicare” Chapter can help you take control of your Medicare. Relief Factorhttps://www.ReliefFactor.comDeclare your independence from pain with Relief Factor—start the 3-Week QuickStart for just $19.95. Patriot Mobilehttp://PatriotMobile.com/DANAVisit online or call 972-PATRIOT and use promo code DANA for a free month of service.Noble Goldhttp://NobleGoldInvestments.com/DANAIf you want to see how physical gold and silver could fit into your portfolio, download Noble Gold Investments FREE Wealth Protection Kit. Subscribe today and stay in the loop on all things news with The Dana Show. Follow us here for more daily clips, updates, and commentary:YoutubeFacebookInstagramXMore InfoWebsite

Tamny explores the misplaced reliance on expert opinion, arguing that the crisis began when epidemiologists became the "leaders of the economy." Comparing this to the 1980s AIDS scare, he notes that early expert predictions are often "first drafts" that can be incorrect. He contrasts 2020 with the 1968 "Hong Kong Flu," which resulted in 100,000 Americandeaths — the equivalent of 250,000 today — but saw no lockdowns, positing that society locked down in 2020 not because it had to, but because technology like Zoom allowed an "elite" class to stay home while others delivered their food. (3)1918 COLORADO

About this episode: Prediabetes—a diagnosis characterized by elevated blood sugar levels that can progress to Type 2 diabetes—is embroiled in debate about whether the condition is clinically "real," and, if so, what the threshold for diagnosis should be. In this episode: Epidemiologist and diabetes expert Elizabeth Selvin breaks down the controversy surrounding prediabetes and why she thinks the diagnosis offers an opportunity for intervention. Guest: Elizabeth Selvin, PhD, MPH, is a professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, where she studies diagnosis and screening for diabetes and prediabetes. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Prediabetes and What It Means: The Epidemiological Evidence—Annual Review of Public Health Prediabetes Explained: An Under-the-Radar and Common Condition That Doesn't Have to Lead to a Diabetes Diagnosis—Johns Hopkins Bloomberg School of Public Health In Praise of Prevention—Hopkins Bloomberg Public Health Magazine Diabetes Prevention Program (DPP)—National Institute of Diabetes and Digestive and Kidney Diseases Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

According to our latest report... 559 Utahns have gotten measles since the outbreak began. Most recently.. it's spread to the University of Utah campus. Joining me live is State Epidemiologist  Dr. Leisha Nolen.

On the KMOJ Morning Show, Freddie Bell speaks with Dr. Ruth Lynfield about the importance of syphilis awareness and public health education. She explains that anyone who is sexually active can contract syphilis, but emphasizes that it can be easily detected through a simple blood test at a clinic. Dr. Lynfield highlights the serious risks of untreated syphilis, particularly during pregnancy, where it can cause significant harm to babies. She also reassures listeners that syphilis is curable with proper treatment, underscoring the importance of regular testing and early intervention. 

This is my annual poison prevention episode. The topic this year is The risks and benefits of using medications for opioid use disorder (MOUD) from a Poison Prevention Educator's Point of View. My guests are Angel Bivens, RPh and Dr. Wendy Stephan. This podcast is for educational purposes only and is not medical advice. Please consult a qualified healthcare professional for medical guidance specific to your situation.   Angel Bivens, RPh is the Managing Director at the Maryland Poison Center in Baltimore, Maryland.    Wendy Stephan, PhD is the Educator and Epidemiologist at the Poison Control Center in Miami, Florida. She is also on the Board of Directors of America's Poison Centers, which is the organization that supports all 53 Poison Centers in the United States.   To read the FULL show notes, visit https://www.thepharmacistsvoice.com.  Click the Podcast tab, and select episode 368.   Follow the podcast to get each new episode! Popular links are below.   Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   Links and info from this episode Poison Help Line Number 1-800-222-1222 America's Poison Centers https://poisoncenters.org/  National Poison Prevention Week is March 15-21, 2026. Use the partner toolkit on https://piper.filecamp.com/s/i/OOt8k1JlBFCc08KH Florida Poison Control www.floridapoisoncontrol.org LinkedIn for Wendy: https://www.linkedin.com/in/wendy-s-315b70178/ Email Wendy wstephan@med.miami.edu X (Twitter): @floridapoison https://x.com/FloridaPoison  Instagram @floridapoisoncontrol https://www.instagram.com/floridapoisoncontrol/  Facebook: https://www.facebook.com/FloridasPCC/  Angel Bivens, RPh on LinkedIn https://www.linkedin.com/in/angelbivens/  Maryland Poison Center: https://www.mdpoison.com/  To find your local poison center: https://poisoncenters.org/  Poison Prevention Press: https://www.mdpoison.com/families/pppress.html (One-page, plain language e-newsletter published every other month on varying topics; all current and previous issues available Poison Prevention Press sign up: http://bit.ly/MPCSignUp) eAntidote Blog: blog.mdpoison.com  Facebook: MarylandPoisonCenter https://www.facebook.com/MarylandPoisonCenter  X (Twitter): @MDPoisonCtr https://x.com/MDPoisonCtr X (Twitter): @MPCToxtidbits https://x.com/MPCToxtidbits  Instagram: @MDPoisonCenter https://www.instagram.com/mdpoisoncenter/  YouTube: Maryland Poison Center https://www.youtube.com/@marylandpoisoncenter/videos  Resources with clinical information for pharmacists: ToxTidbits:  http://bit.ly/ToxTidbits (One-page clinical e-newsletter published monthly on various toxicologic topics; all current and previous issues available ToxTidbits sign up: http://bit.ly/TTBSignUp)   Other Poison Prevention Episodes The Pharmacist's Voice Podcast Episode 27 featuring Dr. Wendy Stephan (July 2020) The Pharmacist's Voice Podcast Episode 87 featuring Angel Bivens (March 2021) The Pharmacist's Voice Podcast Episode 141 featuring Angel Bivens (March 2022) The Pharmacist's Voice Podcast Episodes 203, 204, 205, 206, and 207 (March 2023) The Pharmacist's Voice Podcast Episode 268 featuring Wendy and Angel (March 2024) The Pharmacist's Voice Podcast Episode 321 featuring Wendy and Angel (March 2025)    Take-away messages from Episode 368 in March 2026: Overdose deaths declined between 2023 and 2024.  More than 23 million people are in recovery or have recovered from SUD.  Stigma associated with recovery needs to decline as the number of people in recovery increases. Recovery is possible, and it's probable. Poison Prevention Educators talk to students and communities about substance abuse prevention. Opioid use disorder has many possible entry points, including using pain killers from surgery or dental work, experimentation, and accidental use. Pharmacists have the opportunity to counsel on proper use and storage of MOUD. Counsel to take oral doses in private, so vulnerable individuals cannot see. Vulnerable individuals, like children or DD adults want to imitate the behavior of others. Avoid medication errors. Remove distractions while taking or giving medications, and read the label every time. Keep a personal MAR, if needed, to remember if a dose has been taken.  If a medication error happens, get help (Poison Help or 9-1-1), forgive yourself, and continue your road to recovery.  Narcan is import for anyone in recovery from opioid addiction to have. But, a person experiencing an OD will be unable to give themselves Narcan. Make sure your patients educate the people around them about what Narcan is, when to use it, and how to administer it.  As a general rule, counsel on calling 9-1-1 after giving a dose of Narcan. It can wear off.  Pharmacists should counsel on risks of keeping MOUD in the home: accidental use by a curious, opioid-naive child, confusion with other meds, accidental second dose, etc. Call Poison Help right away with exposure concerns, but skip right to 9-1-1 if the person is not breathing, unconscious, or having a seizure.  Poison Center Staff are experts in poison information. They help healthcare professionals and the general public with questions. If you call, you're in good hands. Adults of all ages may be in recovery. It's not just a health condition for young people.  Get Poison Help Line magnets for your pharmacy, and share them with your patients. If you need some magnets, call 1-800-222-1222.  March is Poison Prevention Month in the United States. National Poison Prevention Week in the US is March 15-21, 2026, and the theme is, "When the unexpected happens, Poison Help is here for you." There is a partner toolkit with images and talking points on https://piper.filecamp.com/s/i/OOt8k1JlBFCc08KH  A complete health history is important. Ask about recovery. Include "in recovery from opioid addiction" as a health condition at the pharmacy and with medical providers.  Advise patients to inscribe, "Do not give opioids" on medic alert jewelry. Similar advice, advise patient to include "do not give opioids" in the "health app" on their smartphone in case of emergency. Pharmacists (this is a tough one). If you see something, say something. Protect your patient's recovery. If something on your prescription monitoring program suggests that your patient is in recovery, but they are trying to fill prescriptions for opioids, protect their recovery. Maybe a well-meaning dentist, doctor, or surgeon wrote a prescription and didn't know the whole story. Or, maybe your patient wants to relapse. If you see something, say something, even if it feels awkward. Prevent relapses and maybe overdoses with patients who have a lower tolerance for opioids.  Be skeptical of natural products and supplements that have been promised to help with opioid withdrawal.  Terminology matters. Know your audience, and reflect their preferred language back to them. Avoid terms that are stigmatizing, like "junkie." When in doubt, ask the person you're speaking with how they prefer to call themselves.    Kim's websites and social media links: ✅ Guest Application Form (The Pharmacist's Voice Podcast) https://bit.ly/41iGogX  ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Pronounce Drug Names Like a Pro © Online Course https://www.kimnewlove.com  ✅ Pharmacist Podcaster Book https://amzn.to/4iAKNBs  ✅ Podcasting Online Course https://www.kimnewlove.com/podcasting  ✅ Private Podcasting Coaching or Consulting https://www.kimnewlove.com/private-coaching  ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with my coach, Dave Jackson from The School of Podcasting! Click my affiliate link: https://community.schoolofpodcasting.com/invitation?code=G43D3G  *New 12-4-25*

Bovine Congestive Heart Failure is the single most costly health-related problem in feedlots with losses surpassing hundreds of thousands of dollars annually in individual operations. Veterinary Brian Vander Ley an Epidemiologist and director of the Great Plains Veterinary Educational Center at the University of Nebraska-Lincoln talks about bovine congestive heart failure and what signs and symptoms to look for in your cattle.

You probably already know that exercise, sleep, a good diet, and spending time in nature are the pillars of a healthy life . But what if there's a fifth pillar we've been undervaluing, and in many cases actively cutting? Our guest today argues that the arts belong in that same category. Daisy Fancourt is a Professor of Psychobiology and Epidemiology at University College London, where she heads the Social Biobehavioural Research Group and directs the World Health Organization's Collaborating Centre on Arts and Health. She's one of the most cited scientists in her field, and her work sits at a genuinely unusual intersection: the rigorous, data-heavy world of epidemiology and the seemingly softer world of creative practice. Her new book, Art Cure: The Science of How the Arts Save Lives, makes a case that's hard to dismiss: that engaging with the arts changes your gene expression, slows your biological aging, reduces your risk of dementia, depression, and chronic pain, and actually helps you live longer. She's done the longitudinal studies across 52 countries, and she's lived it personally, watching her premature daughter's vitals stabilize in the NICU as she sang to her. For designers and creative professionals, this conversation raises some genuinely thorny questions about whether creative work counts, what burnout is actually doing to your body, and why the arts budget is always the first thing to cut even when the data says it probably shouldn't be. Bio Daisy Fancourt (born June 1990) is a British Professor of Psychobiology and Epidemiology at University College London (UCL) and Head of the Social Biobehavioural Research Group. She is a leading researcher on the health impacts of arts, culture, and social prescribing. Fancourt previously worked in NHS arts programs, has published over 300 papers, and directed a major study on COVID-19's mental health impacts. *** Premium Episodes on Design Better This ad-supported episode is available to everyone. If you'd like to hear it ad-free, upgrade to our premium subscription, where you'll get an additional 2 ad-free episodes per month (4 total). Premium subscribers also get access to the documentary Design Disruptors and our growing library of books. New premium benefit: get a behind-the-scenes pass to every episode with The Roundup, where each week we bring you insights and actionable tactics from recent episodes. You'll also get access to our monthly AMAs with former guests, ad-free episodes, discounts and early access to workshops, and our monthly newsletter The Brief that compiles salient insights, quotes, readings, and creative processes uncovered in the show. And subscribers at the annual level now get access to the Design Better Toolkit, which gets you major discounts and free access to tools and courses that will help you unlock new skills, make your workflow more efficient, and take your creativity further. Upgrade to paid *** If you're interested in sponsoring the show, please contact us at: sponsors@thecuriositydepartment.com If you'd like to submit a guest idea, please contact us at: contact@thecuriositydepartment.com

In this two part series, Aarati tells the story of the epidemiologist who realized there was a link between prenatal x-rays and childhood cancer. She  undertook a lifelong crusade to warn people against the dangers of radiation.Support the showFor more information and sources for this episode, visit https://www.smartteapodcast.com.

As Black History Month draws to a close, we take a closer look at an organization that's quietly shaped generations of opportunity. Dr. Walter Kimbrough, Executive Vice President at UNCF joined me to talk about the legacy and future of the United Negro College Fund. AND would you know what to do if you or someone you were with was poisoned? It happens to someone every few seconds in our country. I discussed the dangers with Dr. Krys Johnson, Epidemiologist for America's Poison CentersSee omnystudio.com/listener for privacy information.

The U.S. Food and Drug Administration announced recently that it will not review Moderna's mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and outside the industry concerned about the Trump administration's approach to vaccine development and recommendations. Amna Nawaz discussed more with Michael Osterholm. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

The Smart 7 is an award winning daily podcast, in association with METRO that gives you everything you need to know in 7 minutes, at 7am, 7 days a week...With over 20 million downloads and consistently charting, including as No. 1 News Podcast on Spotify, we're a trusted source for people every day and the Sunday 7 won a Gold Award as “Best Conversation Starter” in the International Signal Podcast Awards If you're enjoying it, please follow, share, or even post a review, it all helps...Today's episode includes the following guests:Dr Elly Hanson - Clinical Psychologist and Researcher Wesley Lisbie - Assistant Headteacher at the E-ACT Heartland Academy, BirminghamSanjaya Ranasinghe - Vice President for Research and Development, WiredscoreWill Guyatt - The Smart 7's Tech Guru Chris Lockett - Senior Vice President of Castrol Technology Global research and developmentDr Celine Gounder - CBS News medical contributor, Epidemiologist and Infectious Disease specialistNatasa Sarkic - Lead Archaeologist at Racesa, in CroatiaDoctor Alex Woods - NHS Trauma and Orthopaedic Surgeon, and Founder of start up Newrotex Wilkie - An Orca, who is also a talented mimic Contact us over @TheSmart7pod or visit www.thesmart7.com or find out more at www.metro.co.uk Presented by Ciara Revins, written by Liam Thompson, researched by Lucie Lewis and produced by Daft Doris. Hosted on Acast. See acast.com/privacy for more information.

From wellness products, to fragrances, to the haircare many of us grew up using, Black women are routinely exposed to harmful chemicals in products marketed directly to us. So what do we do when our everyday routines are shaped by systems that often put our health at risk? These exposures don’t happen in isolation; they build over time, contributing to serious and sometimes chronic health conditions that are deeply tied to environmental racism at a systemic level. But there are changes and solutions we can implement to curb these risks that contribute to a healthier, longer life. Here to break all of this down is Dr. Tamarra James-Todd, Epidemiologist and Professor of Environmental Reproductive Epidemiology at Harvard University. Dr. James-Todd directs the Environmental Reproductive Justice Lab, where she studies how chemicals in consumer products and our broader environment impact Black women’s health across the lifespan. Her work not only exposes the inequities in these systems, but puts a focus on empowering communities with the knowledge and tools to reduce risks of harm. Today, we’re unpacking what environmental racism really looks like, how it shows up in the products we use every day, and what it will take to protect Black women’s health. About the Podcast The Therapy for Black Girls Podcast is a weekly conversation with Dr. Joy Harden Bradford, a licensed Psychologist in Atlanta, Georgia, about all things mental health, personal development, and all the small decisions we can make to become the best possible versions of ourselves. Resources & Announcements Want to reflect on this conversation in community? Join us inside our Patreon community where we’re unpacking this episode together and sharing practical ways to reduce exposure—without overwhelm. Where to Find Our Guest Website Stay Connected​ Is there a topic you'd like covered on the podcast? Submit it at therapyforblackgirls.com/mailbox. If you're looking for a therapist in your area, check out the directory at https://www.therapyforblackgirls.com/directory. Grab your copy of our guided affirmation and other TBG Merch at therapyforblackgirls.com/shop. The hashtag for the podcast is #TBGinSession. Make sure to follow us on social media: Instagram: @therapyforblackgirls Facebook: @therapyforblackgirls Our Production Team Executive Producers: Dennison Bradford & Gabrielle Collins Director of Podcast & Digital Content: Ellice Ellis Producers: Tyree Rush & Ndeye Thioubou See omnystudio.com/listener for privacy information.

If you want to understand how Robert F. Kennedy Jr. became the face of American public health, you have to go back to the Covid era. Medical authorities spoke with certainty: Trust the science. Don't listen to skeptics. But a lot of people stopped trusting experts entirely when outsiders got some things right and the establishment got some things wrong. Now those outsiders are in charge, like my guest this week. Dr. Jay Bhattacharya is the director of the National Institutes of Health. I wanted to know: Can an outsider restore trust in public health institutions without undermining trust even more?02:11 - How the “fringe epidemiologist” came to be08:18 - What went wrong while “crushing COVID-19”15:18 - “The responsibility of public health leaders”28:42 - Reforming public health and the NIH42:52 - Three areas of controversy plaguing public health1:00:52 - Success metrics(A full transcript of this episode is available on the Times website.)Thoughts? Email us at interestingtimes@nytimes.com. Please subscribe to our YouTube Channel, Interesting Times with Ross Douthat. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Missouri Department of Health's State Epidemiologist, Dr George Turabelidze, joins Megan Lynch looking at the recent spike in flu cases across the state. He says we may see the most diagnosed cases since the pandemic.

A leading addiction expert explains how he's driven by the memory of a friend who died, and why he believes giving data on the drug supply to people on the street is more important than using it to inform national drug policy.Guest:Nabarun Dasgupta, Epidemiologist, University of North Carolina Street Drug Analysis Lab and Opioid Data LabLearn more and read a full transcript on our website.Help us unlock a $5,000 match by becoming one of 200 new donors at tradeoffs.org/donate.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news. Hosted on Acast. See acast.com/privacy for more information.

Co-hosts Ryan Piansky, a graduate student and patient advocate living with eosinophilic esophagitis (EoE) and eosinophilic asthma, and Holly Knotowicz, a speech-language pathologist living with EoE who serves on APFED's Health Sciences Advisory Council, interview Evan S. Dellon, MD, and Elizabeth T. Jensen, PhD, about a paper they published on predictors of patients receiving no medication for treatment of eosinophilic esophagitis. Disclaimer: The information provided in this podcast is designed to support, not replace, the relationship between listeners and their healthcare providers. Opinions, information, and recommendations shared in this podcast are not a substitute for medical advice. Decisions related to medical care should be made with your healthcare provider. Opinions and views of guests and co-hosts are their own.   Key Takeaways: [:52] Co-host Ryan Piansky introduces the episode, brought to you thanks to the support of Education Partners GSK, Sanofi, Regeneron, and Takeda. Ryan introduces co-host Holly Knotowicz.   [1:14] Holly introduces today's topic, predictors of not using medication for EoE, and today's guests, Dr. Evan Dellon and Dr. Elizabeth Jensen.   [1:29] Dr. Dellon is an Adjunct Professor of Epidemiology at the University of North Carolina School of Medicine in Chapel Hill. He is also the Director of the UNC Center for Esophageal Diseases and Swallowing.   [1:42] Dr. Dellon's main research interest is in the epidemiology, pathogenesis, diagnosis, treatment, and outcomes of eosinophilic esophagitis (EoE) and eosinophilic GI diseases (EGIDs).   [1:55] Dr. Jensen is a Professor of Epidemiology with a specific expertise in reproductive, perinatal, and pediatric epidemiology. She has appointments at both Wake Forest University School of Medicine and the University of North Carolina at Chapel Hill.   [2:07] Her research primarily focuses on etiologic factors in the development of pediatric immune-mediated chronic diseases, including understanding factors contributing to disparities in health outcomes.   [2:19] Both Dr. Dellon and Dr. Jensen also serve on the Steering Committee for EGID Partners Registry.   [2:24] Ryan thanks Dr. Dellon and Dr. Jensen for joining the podcast today.   [2:29] Dr. Dellon was the first guest on this podcast. It is wonderful to have him back for the 50th episode! Dr. Dellon is one of Ryan's GI specialists. Ryan recently went to North Carolina to get a scope with him.   [3:03] Dr. Dellon is an adult gastroenterologist at the University of North Carolina at Chapel Hill. He directs the Center for Esophageal Diseases and Swallowing. Clinically and research-wise, he is focused on EoE and other eosinophilic GI diseases.   [3:19] His research interests span the entire field, from epidemiology, diagnosis, biomarkers, risk factors, outcomes, and a lot of work, more recently, on treatments.   [3:33] Dr. Jensen has been on the podcast before, on Episode 27. Holly invites Dr. Jensen to tell the listeners more about herself and her work with eosinophilic diseases.   [3:46] Dr. Jensen has been working on eosinophilic gastrointestinal diseases for about 15 years. She started some of the early work around understanding possible risk factors for the development of disease.   [4:04] She has gone on to support lots of other research projects, including some with Dr. Dellon, where they're looking at gene-environment interactions in relation to developing EoE.   [4:15] She is also looking at reproductive factors as they relate to EoE, disparities in diagnosis, and more. It's been an exciting research trajectory, starting with what we knew very little about and building to an increasing understanding of why EoE develops.   [5:00] Dr. Dellon explains that EoE stands for eosinophilic esophagitis, a chronic allergic condition of the esophagus.   [5:08] You can think of EoE as asthma of the esophagus or eczema of the esophagus, although in general, people don't grow out of EoE, like they might grow out of eczema or asthma. When people have EoE, it is a long-term condition.   [5:24] Eosinophils are a type of white blood cell, specializing in allergy responses. Normally, they are not in the esophagus. When we see them there, we worry about an allergic process. When that happens, that's EoE.   [5:40] Over time, the inflammation seen in EoE and other allergic cell activity causes swelling and irritation in the esophagus. Early on, this often leads to a range of upper GI symptoms — including poor growth or failure to thrive in young children, abdominal pain, nausea, and symptoms that can mimic reflux.   [5:58] In older kids, symptoms are more about trouble swallowing. That's because the swelling that happens initially, over time, may turn into scar tissue. So the esophagus can narrow and cause swallowing symptoms like food impaction.   [6:16] Ryan speaks of living with EoE for decades and trying the full range of treatment options: food elimination, PPIs, steroids, and, more recently, biologics.   [6:36] Dr. Dellon says Ryan's history is a good overview of how EoE is treated. There are two general approaches to treating the underlying condition: using medicines and/or eliminating foods that we think may trigger EoE from the diet.   [6:57] For a lot of people, EoE is a food-triggered allergic condition.   [7:01] The other thing that has to happen in parallel is surveying for scar tissue in the esophagus. If that's present and people have trouble swallowing, sometimes stretching the esophagus is needed through esophageal dilation.   [7:14] There are three categories of medicines used for treatment. Proton pump inhibitors are reflux meds, but they also have an anti-allergy effect in the esophagus.   [7:29] Topical steroids are used to coat the esophagus and produce an anti-inflammatory effect. The FDA has approved a budesonide oral suspension for that.   [7:39] Biologics, which are generally systemic medications, often injectable, can target different allergic factors. Dupilumab is approved now, and there are other biologics that are being researched as potential treatments.   [7:51] Even though EoE is considered an allergic condition, we don't have a test to tell people what they are allergic to. If it's a food allergy, we do an empiric elimination diet because allergy tests aren't accurate enough to tell us what the EoE triggers are.   [8:10] People will eliminate foods that we know are the most common triggers, like milk protein, dairy, wheat, egg, soy, and other top allergens. You can create a diet like that and then have a response to the diet elimination.   [8:31] Dr. Jensen and Dr. Dellon recently published an abstract in the American Journal of Gastroenterology about people with EoE who are not taking any medicine for it. Dr. Jensen calls it a real-world data study, leveraging electronic health record patient data.   [8:51] It gives you an impression of what is actually happening, in terms of treatments for patients, as opposed to a randomized control trial, which is a fairly selected patient population. This is everybody who has been diagnosed, and then what happens with them.   [9:10] Because of that, it gives you a wide spectrum of patients. Some patients are going to be relatively asymptomatic. It may be that we arrived at their diagnosis while working them up for other potential diagnoses.   [9:28] Other patients are going to have rather significant impacts from the disease. We wanted to get an idea of what is actually happening out there with the full breadth of the patient population that is getting diagnosed with EoE.   [9:45] Dr. Jensen was not surprised to learn that there are patients who had no pharmacologic treatment.   [9:58] Some patients are relatively asymptomatic, and others are not interested in pursuing medications initially or are early in their disease process and still exploring dietary treatment options.   [10:28] Holly sees patients from infancy to geriatrics, and if they're not having symptoms, they wonder why bother treating it.   [10:42] Dr. Jensen says it's a point of debate on the implications of somebody who has the disease and goes untreated. What does that look like long-term? Are they going to develop more of that fibrostenotic pattern in their esophagus without treatment?   [11:07] This is a question we're still trying to answer. There is some suggestion that for some patients who don't manage their disease, we very well may be looking at a food impaction in the future.   [11:19] Dr. Dellon says we know overall for the population of EoE patients, but it's hard to know for a specific patient. We have a bunch of studies now that look at how long people have symptoms before they're diagnosed. There's a wide range.   [11:39] Some people get symptoms and get diagnosed right away. Others might have symptoms for 20 or 30 years that they ignore, or don't have access to healthcare, or the diagnosis is missed.   [11:51] What we see consistently is that people who may be diagnosed within a year or two may only have a 10 or 20% chance of having that stricture and scar tissue in the esophagus, whereas people who go 20 years, it might be 80% or more.   [12:06] It's not everybody who has EoE who might end up with that scar tissue, but certainly, it's suggested that it's a large majority.   [12:16] That's before diagnosis. We have data that shows that after diagnosis, if people go a long time without treatment or without being seen in care, they also have an increasing rate of developing strictures.    [12:29] In general, the idea is yes, you should treat EoE, because on average, people are going to develop scar tissue and more symptoms. For the patient in front of you with EoE but no symptoms, what are the chances it's going to get worse? You don't know.   [13:04] There are two caveats with that. The first is what we mean by symptoms. Kids may have vomiting and growth problems. Adults can eat carefully, avoiding foods that hang up in the esophagus, like breads and overcooked meats, sticky rice, and other foods.   [13:24] Adults can eat slowly, drink a lot of liquid, and not perceive they have symptoms. When someone tells Dr. Dellon they don't have symptoms, he will quiz them about that. He'll even ask about swallowing pills.    [13:40] Often, you can pick up symptoms that maybe the person didn't even realize they were having. In that case, that can give you some impetus to treat.   [13:48] If there really are no symptoms, Dr. Dellon thinks we're at a point where we don't really know what to do.   [13:54] Dr. Dellon just saw a patient who had a lot of eosinophils in their small bowel with absolutely no GI symptoms. He said, "I can't diagnose you with eosinophilic enteritis, but you may develop symptoms." People like that, he will monitor in the clinic.   [14:14] Dr. Dellon will discuss it with them each time they come back for a clinic visit.   [14:19] Holly is a speech pathologist, but also sees people for feeding and swallowing. The local gastroenterologist refers patients who choose not to treat their EoE to her. Holly teaches them things they should be looking out for.   [14:39] If your pills get stuck or if you're downing 18 ounces during a mealtime, maybe it's time to treat it. People don't see these coping mechanisms they use that are impacting their quality of life. They've normalized it.   [15:30] Dr. Dellon says, of these people who aren't treated, there's probably a subset who appropriately are being observed and don't have a medicine treatment or are on a diet elimination.   [15:43] There's also probably a subset who are inappropriately not on treatment. It especially can happen with students who were under good control with their pediatric provider, but moved away to college and didn't transfer to adult care.   [16:08] They ultimately come back with a lot of symptoms that have progressed over six to eight years.   [16:18] Ryan meets newly diagnosed adult patients at APFED's conferences, who say they have no symptoms, but chicken gets caught in their throat. They got diagnosed when they went to the ER with a food impaction.   [16:38] Ryan says you have to wonder at what point that starts to get reflected in patient charts. Are those cases documented where someone is untreated and now has EoE?   [16:49] Ryan asks in the study, "What is the target EGID Cohort and why was it selected to study EoE? What sort of patients were captured as part of that data set?"   [16:58] Dr. Jensen said they identified patients with the ICD-10 code for a diagnosis of EoE. Then they looked to see if there was evidence of symptoms or complications in relation to EoE. This was hard; some of these are relatively non-specific symptoms.   [17:23] These patients may have been seeking care and may have been experiencing some symptoms that may or may not have made it into the chart. That's one of the challenges with real-world data analyses.   [17:38] Dr. Jensen says they are using data that was collected for documenting clinical care and for billing for clinical care, not for research, so it comes with some caveats when doing research with this data.   [18:08] Research using electronic health records gives a real-world perspective on patients who are seeking care or have a diagnosis of EoE, as opposed to a study trying to enroll a patient population that potentially isn't representative of the breadth of individuals living with EoE.   [18:39] Dr. Dellon says another advantage of real-world data is the number of patients. The largest randomized controlled trials in EoE might have 400 patients, and they are incredibly expensive to do.   [18:52] A study of electronic health records (EHR) is reporting on the analysis of just under 1,000. The cohort, combined from three different centers, has more than 1,400 people, a more representative, larger population.    [19:16] Dr. Dellon says when you read the results, understand the limitations and strengths of a study of health records, to help contextualize the information.   [19:41] Dr. Dellon says it's always easier to recognize the typical presentations. Materials about EoE and studies he has done that led to medicine approvals have focused on trouble swallowing. That can be relatively easily measured.   [20:01] Patients often come to receive care with a food impaction, which can be impactful on life, and somewhat public, if in a restaurant or at work. Typical symptoms are also the ones that get you diagnosed and may be easier to treat.   [20:26] Dr. Dellon wonders if maybe people don't treat some of the atypical symptoms because it's not appreciated that they can be related to EoE.   [20:42] Holly was diagnosed as an adult. Ryan was diagnosed as a toddler. Holly asks what are some of the challenges people face in getting an EoE diagnosis.   [20:56] Dr. Jensen says symptoms can sometimes be fairly non-specific. There's some ongoing work by the CEGIR Consortium trying to understand what happens when patients come into the emergency department with a food bolus impaction.   [21:28] Dr. Jensen explains that we see there's quite a bit of variation in how that gets managed, and if they get a biopsy. You have to have a biopsy of the esophagus to get a diagnosis of EoE.   [21:45] If you think about the steps that need to happen to get a diagnosis of EoE, that can present barriers for some groups to ultimately get that diagnosis.   [21:56] There's also been some literature around a potential assumption about which patients are more likely to be at risk. Some of that is still ongoing. We know that EoE occurs more commonly in males in roughly a two-to-one ratio. Not exclusively in males, obviously, but a little more often in males.   [22:20] We don't know anything about other groups of patients that may be at higher risk. That's ongoing work that we're still trying to understand. That in itself can also be a barrier when there are assumptions about who is or isn't likely to have EoE.   [23:02] Dr. Dellon says that in adolescents and adults, the typical symptoms are trouble swallowing and food sticking, which have many causes besides EoE, some of which are more common.   [23:18] In that population, heartburn is common. Patients may report terrible reflux that, on questioning, sounds more like trouble swallowing than GERD. Sometimes, with EoE, you may have reflux that doesn't improve. Is it EoE, reflux, or both?   [24:05] Some people will have chest discomfort. There are some reports of worsening symptoms with exercise, which brings up cardiac questions that have to be ruled out first.   [24:19] Dr. Dellon mentions some more atypical symptoms. An adult having pain in the upper abdomen could have EoE. In children, the symptoms could be anything in the GI tract. Some women might have atypical symptoms with less trouble swallowing.   [24:58] Some racial minorities may have those kinds of symptoms, as well. If you're not thinking of the condition, it's hard to make the diagnosis.   [25:08] Dr. Jensen notes that there are different cultural norms around expressing symptoms and dietary patterns, which may make it difficult to parse out a diagnosis.   [25:27] Ryan cites a past episode where access to a GI specialist played a role in diagnosing patients with EoE. Do white males have more EoE, or are their concerns just listened to more seriously?   [25:57] Ryan's parents were told when he was two that he was throwing up for attention. He believes that these days, he'd have a much easier time convincing a doctor to listen to him. From speaking to physicians, Ryan believes access is a wide issue in the field.   [26:23] Dr. Dellon tells of working with researchers at Mayo in Arizona and the Children's Hospital of Phoenix. They have a large population of Hispanic children with EoE, much larger than has been reported elsewhere. They're working on characterizing that.   [26:49] Dr. Dellon describes an experience with a visiting trainee from Mexico City, where there was not a lot of EoE reported. The trainee went back and looked at the biopsies there, and it turned out they were not performing biopsies on patients with dysphagia in Mexico City.   [27:13] When he looked at the patients who ended up getting biopsies, they found EoE in 10% of patients. That's similar to what's reported out of centers in the developed world. As people are thinking about it more, we will see more detection of it.   [27:30] Dr. Dellon believes those kinds of papers will be out in the next couple of months, to a year.   [27:36] Holly has had licensure in Arizona for about 11 years. She has had nine referrals recently of children with EoE from Arizona. Normally, it's been one or two that she met at a conference.   [28:00] Ryan asks about the research on patients not having their EoE treated pharmacologically. Some treat it with food avoidance and dietary therapy. Ryan notes that he can't have applesauce, as it is a trigger for his EoE.   [28:54] Dr. Jensen says that's one of the challenges in using the EHR data. That kind of information is only available to the researchers through free text. That's a limitation of the study, assessing the use of dietary elimination approaches.   [29:11] Holly says some of her patients have things listed as allergies that are food sensitivities. Ryan says it's helpful for the patients to have their food sensitivities listed along with their food allergies, but it makes records more difficult to parse for research.   [30:14] Dr. Dellon says they identify EoE by billing code, but the codes are not always used accurately. Natural Language Processing can train a computer system to find important phrases. Their collaborators working on the real-world data are using it.   [30:59] Dr. Dellon hopes that this will be a future direction for this research to find anything in the text related to diet elimination.   [31:32] Dr. Jensen says that older patients were less likely to seek medication therapy. She says it's probably for a couple of reasons. First, older patients may have been living with the disease for a long time and have had compensatory mechanisms in place.   [32:03] The other reason may be senescence or burnout of the disease, long-term. Patients may be less symptomatic as they get older. That's a question that remains to be answered for EoE. It has been seen in some other disease processes.   [32:32] Dr. Dellon says there's not much data specifically looking at EoE in the older population. Dr. Dellon did work years ago with another doctor, and they found that older patients had a better response to some treatments, particularly topical steroids.   [32:54] It wasn't clear whether it was a milder aspect of the disease, easier to treat, or because they were older and more responsible, taking their medicines as prescribed, and having a better response rate. It's the flip side of work in the pediatric population.   [33:16] There is an increasingly aging population with EoE. Young EoE patients will someday be over 65. Dr. Dellon hopes there will be a cure by that point, but it's an expanding population now.   [33:38] Dr. Jensen says only a few sites are contributing data, so they hope to add additional sites to the study. For some of the less common outcomes, they need a pretty large patient sample to ask some of those kinds of questions.   [33:55] They will continue to follow up on some of the work that this abstract touched on and try to understand some of these issues more deeply.   [34:06] Dr. Dellon mentions other work within the cohort. Using Natural Language Processing, they are looking at characterizing endoscopy information and reporting it without a manual review of reports and codes. You can't get that from billing data.   [34:29] Similarly, they are trying to classify patient severity by the Index of Severity with EoE, and layer that on looking at treatments and outcomes based on disease severity. Those are a couple of other directions where this cohort is going.   [34:43] Holly mentions that this is one of many research projects Dr. Jensen and Dr. Dellon have collaborated on together. They also collaborate through EGID Partners. Holly asks them to share a little bit about that.   [34:53] Dr. Jensen says EGID Partners is an online registry where individuals, caregivers, and parents of children affected with EGIDs can join.   [35:07] EGID Partners also needs people who don't live with an EGID to join, as controls. That gives the ability to compare those who are experiencing an EGID relative to those who aren't.   [35:22] When you join EGID Partners, they provide you with a set of questionnaires to complete. Periodically, they push out a few more questionnaires.   [35:33] EGID Partners has provided some really great information about patient experience and answered questions that patients want to know about, like joint pain and symptoms outside the GI tract.   [36:04] To date, there are close to 900 participants in the registry from all over the world. As it continues to grow, it will give the ability to look at the patient experience in different geographical areas.   [36:26] Dr. Dellon says we try to have it be interactive, because it is a collaboration with patients. The Steering Committee works with APFED and other patient advocacy groups from around the world.    [36:41] The EGID Partners website shows general patient locations anonymously. It shows the breakdown of adults with the condition and caregivers of children with the condition, the symptom distribution, and the treatment distribution.   [37:03] As papers get published and abstracts are presented, EGID Partners puts them on the website. Once someone joins, they can suggest a research idea. Many of the studies they have done have come from patient suggestions.   [37:20] If there's an interesting idea for a survey, EGID Partners can push out a survey to everybody in the group and answer questions relatively quickly.   [37:57] Dr. Dellon says a paper came out recently about telehealth. EoE care, in particular, is a good model for telehealth because it can expand access for patients who don't have providers in their area.   [38:22] EoE is a condition where care involves a lot of discussion but not a lot of need for physical exams and direct contact, so telehealth can make things very efficient.    [38:52] EGID Partners surveyed patients about telehealth. They thought it was efficient and saved time, and they had the same kind of interactions as in person. In general, in-state insurance covered it. Patients were happy to do those kinds of visits again.   [39:27] Holly says Dr. Furuta, herself, and others were published in the Gastroenterology journal in 2019 about starting to do telehealth because patients coming to the Children's Hospital of Colorado from out of state had no local access to feeding therapy.   [39:50] Holly went to the board, and they allowed her to get licensure in different states. She started with some of the most impacted patients in Texas and Florida in 2011 and 2012. They collected data. They published in 2019 about telehealth's positive impact.   [40:13] When 2020 rolled around, Holly had trained a bunch of people on how to do feeding therapy via telehealth. You have to do all kinds of things, like make yourself disappear, to keep the kids engaged and in their chairs!   [40:25] Now it is Holly's primary practice. She has licenses in nine states. She sees people all over the country. With her diagnosis, her physicians at Mass General have telehealth licensure in Maine. She gets to do telehealth with them instead of driving two hours.   [40:53] Dr. Jensen tells of two of the things they hope to do at EGID Partners. One is trying to understand more about reproductive health for patients with an EGID diagnosis. Only a few studies have looked at this question, and with very small samples.   [41:15] As more people register for EGID Partners, Dr. Jensen is hoping to be able to ask some questions related to reproductive health outcomes.   [41:27] The second goal is a survey suggested by the Student Advisory Committee, asking questions related to the burden of disease specific to the teen population.   [41:48] This diagnosis can hit that population particularly hard, at a time when they are trying to build and sustain friendships and are transitioning to adult care and moving away from home. This patient population has a unique perspective we wanted to hear.   [42:11] Dr. Jensen and Dr. Dellon work on all kinds of other projects, too.   [42:22] Dr. Dellon says they have done a lot of work on the early-life factors that may predispose to EoE. They are working on a large epidemiologic study to get some insight into early-life factors, including factors that can be measured in baby teeth.   [42:42] That's outside of EGID Partners. It's been ongoing, and they're getting close, maybe over the next couple of years, to having some results.   [43:03] Ryan says all of those projects sound so interesting. We need to have you guys back to dive into those results when you have something finalized.   [43:15] For our listeners who want to learn more about eosinophilic disorders, we encourage you to visit apfed.org and check out the links in the show notes below.   [43:22] If you're looking to find specialists who treat eosinophilic disorders, we encourage you to use APFED's Specialist Finder at apfed.org/specialist.   [43:31] If you'd like to connect with others impacted by eosinophilic diseases, please join APFED's online community on the Inspire Network at apfed.org/connections.   [43:41] Ryan thanks Dr. Dellon and Dr. Jensen for joining us today. This was a fantastic conversation. Holly also thanks APFED's Education Partners GSK, Sanofi, Regeneron, and Takeda for supporting this episode.   Mentioned in This Episode: Evan S. Dellon, MD, MPH, Academic Gastroenterologist, University of North Carolina School of Medicine   Elizabeth T. Jensen, MPH, PhD, Epidemiologist, Wake Forest University School of Medicine, University of North Carolina at Chapel Hill   Predictors of Patients Receiving No Medication for Treatment of Eosinophilic Esophagitis in the United States: Data from the TARGET-EGIDS Cohort   Episode 15: Access to Specialty Care for Eosinophilic Esophagitis (EoE)   APFED on YouTube, Twitter, Facebook, Pinterest, Instagram Real Talk: Eosinophilic Diseases Podcast apfed.org/specialist apfed.org/connections apfed.org/research/clinical-trials   Education Partners: This episode of APFED's podcast is brought to you thanks to the support of GSK, Sanofi, Regeneron, and Takeda.   Tweetables:   "I've been working on eosinophilic gastrointestinal diseases for about 15 years. I started some of the early work around understanding possible risk factors for the development of disease. I've gone on to support lots of other research projects." — Elizabeth T. Jensen, MPH, PhD   "You can think of EoE as asthma of the esophagus or eczema of the esophagus, although in general, people don't grow out of EoE, like they might grow out of eczema or asthma. When people have it, it really is a long-term condition." — Evan S. Dellon, MD, MPH   "There are two general approaches to treating the underlying condition, … using medicines and/or eliminating foods from the diet that we think may trigger EoE. I should say, for a lot of people, EoE is a food-triggered allergic condition." — Evan S. Dellon, MD, MPH   "I didn't find it that surprising [that there are patients who had no treatment]. Some patients are relatively asymptomatic, and others are not interested in pursuing medications initially or are … still exploring dietary treatment options." — Elizabeth T. Jensen, MPH, PhD   "We have a bunch of studies now that look at how long people have symptoms before they're diagnosed. There's a wide range. Some people get symptoms and are diagnosed right away. Other people might have symptoms for 20 or 30 years." — Evan S. Dellon, MD, MPH   "EGID Partners is an online registry where individuals, caregivers, and parents of children affected with EGIDs can join. EGID Partners also needs people who don't live with an EGID to join, as controls." — Elizabeth T. Jensen, MPH, PhD

Send us a textSeth Berkley, MD has been at the front lines of the world's biggest battles against infectious disease. As the longtime CEO of Gavi, the Vaccine Alliance, the cofounder of COVAX, and the founder of the International AIDS Vaccine Initiative, Berkley has helped bring lifesaving vaccines to billions of people.In his new book, FAIR DOSES: An Insider's Story of the Pandemic and the Global Fight for Vaccine Equity, Berkley lays out the hard truths of what went wrong during COVID—and how we can do better next time. From the rise of vaccine nationalism and political roadblocks to the explosion of misinformation, Berkley explains why inequitable vaccine access cost millions of lives and weakened global stability.On this episode of FUTUREPROOF., we discuss:Why the next pandemic is not a question of if, but whenWhat COVID-19 revealed about the politics of global healthHow vaccine nationalism and misinformation threaten our collective safetyLessons from COVAX and how to design faster, fairer systems in the futureWhy global cooperation isn't just moral—it's economic and existentialThis is a candid conversation about science, trust, and survival in a world that will inevitably face future pandemics.

Epidemiologist Joseph Mangano, head of Radiation and Public Health Project (RPHP) This Week’s Featured Interview: Such a national study of the health risks posed by existing reactors should: LINK: Why a national cancer study near US reactors must be conducted before any new expansion of nuclear power – original article by Joseph Mangano and the...

In the chaos of a global pandemic, clarity and trust became as vital as any vaccine. In this episode of the Public Health Insight Podcast, Dr. Tista Ghosh reveals the untold stories behind rural and urban divides, the confusion of shifting public health guidance, and the fragile foundation of trust that shapes our collective response. This conversation cuts through the noise to spotlight the real challenges and urgent lessons that public health must face before the next crisis arrives.References for Our Discussion◼️Tista Ghosh | Author◼️Bird flu's deadly return: Are we flying blind into the next pandemic?◼️Trump's Cuts to FEMA Leave Us Unprepared for Disasters ◼️The CDC at a Crossroads: Budget Cuts, Public Health, and the Growing Threat of Infectious Diseases ◼️Social Impact Authors: How & Why Author Tista S Ghosh Is Helping To Change Our WorldGuest◼️Dr. Tista Ghosh, MD, MPH; Physician, Epidemiologist, Award-winning Health Journalist, & AuthorHost & Producer(s)◼️ Gordon Thane, BMSc, MPH, PMP®Production Notes◼️ Music from Johnny Harris x Tom Fox: The Music RoomSubscribe to the NewsletterSubscribe to The Insight newsletter so you don't miss out on the latest podcast episodes, live events, job skills, learning opportunities, and other engaging professional development content here.Leave Us Some FeedbackIf you enjoy our podcasts, be sure to subscribe and leave us a rating on Apple Podcast or Spotify, and spread the word to your friends to help us get discovered by more people. You can also interact directly with the podcast episodes on Spotify using the new “comment” feature! We'd love to hear what you think.Send us a Text Message to let us know what you think.

We treated the world as if everyone was living the same pandemic. But what if that was our biggest mistake? Dr. Tista Ghosh takes us inside her new book, Before The Next Crisis, sharing untold stories from the frontlines—stories that challenge what we thought we knew about COVID-19. This episode dives deep into the chaos, confusion, and courage that defined the crisis, and asks: how do we rebuild trust in science, and what should we do differently next time?References for Our Discussion◼️Tista Ghosh | Author◼️Bird flu's deadly return: Are we flying blind into the next pandemic?◼️Trump's Cuts to FEMA Leave Us Unprepared for Disasters ◼️The CDC at a Crossroads: Budget Cuts, Public Health, and the Growing Threat of Infectious Diseases ◼️Social Impact Authors: How & Why Author Tista S Ghosh Is Helping To Change Our WorldGuest◼️Dr. Tista Ghosh, MD, MPH; Physician, Epidemiologist, Award-winning Health Journalist, & AuthorHost & Producer(s)◼️ Gordon Thane, BMSc, MPH, PMP®Production Notes◼️ Music from Johnny Harris x Tom Fox: The Music RoomSubscribe to the NewsletterSubscribe to The Insight newsletter so you don't miss out on the latest podcast episodes, live events, job skills, learning opportunities, and other engaging professional development content here.Leave Us Some FeedbackIf you enjoy our podcasts, be sure to subscribe and leave us a rating on Apple Podcast or Spotify, and spread the word to your friends to help us get discovered by more people. You can also interact directly with the podcast episodes on Spotify using the new “comment” feature! We'd love to hear what you think.Send us a Text Message to let us know what you think.

Vidcast:  https://www.instagram.com/p/DPazFqDjUYF/If you have a problem with alcohol, so-called alcohol use disorder, you are at a more than 50% higher risk of developing dementia.  Epidemiologists from Britain's University of Oxford and Yale studied adults with data in the UK Biobank and the US Million Veteran Program.The tabulated case data revealed that heavy drinkers consuming more than 40 alcoholic drinks/week have 41% higher risk of dementia compared with non-drinkers and those with alcohol use disorder have a 41% higher risk. A genetic analysis shows that every standard deviation increase in the log transformed number of drinks/week is associated with 15% higher dementia risk.The researchers emphasize that those having an occasional drink need not worry about this dementia risk.  Again, moderation is the best policy.https://ebm.bmj.com/content/early/2025/09/16/bmjebm-2025-113913#alcohol #dementia 

From family stories of freedom fighters to the chaos of COVID-19, Dr. Tista Ghosh's journey is anything but ordinary. In this episode of the Public Health Insight Podcast, she opens up about growing up between cultures, navigating political minefields as Colorado's Chief Medical Officer, and what she learned listening to frontline workers, which she captures in her new book, Before The Next Crisis.References for Our Discussion◼️Tista Ghosh | Author◼️Bird flu's deadly return: Are we flying blind into the next pandemic?◼️Trump's Cuts to FEMA Leave Us Unprepared for Disasters ◼️The CDC at a Crossroads: Budget Cuts, Public Health, and the Growing Threat of Infectious Diseases ◼️Social Impact Authors: How & Why Author Tista S Ghosh Is Helping To Change Our WorldGuest◼️Dr. Tista Ghosh, MD, MPH; Physician, Epidemiologist, Award-winning Health Journalist, & AuthorHost & Producer(s)◼️ Gordon Thane, BMSc, MPH, PMP®Production Notes◼️ Music from Johnny Harris x Tom Fox: The Music RoomSubscribe to the NewsletterSubscribe to The Insight newsletter so you don't miss out on the latest podcast episodes, live events, job skills, learning opportunities, and other engaging professional development content here.Leave Us Some FeedbackIf you enjoy our podcasts, be sure to subscribe and leave us a rating on Apple Podcast or Spotify, and spread the word to your friends to help us get discovered by more people. You can also interact directly with the podcast episodes on Spotify using the new “comment” feature! We'd love to hear what you think.Send us a Text Message to let us know what you think.

Epidemiologist & Health Economist - New England Complex Systems Institute, Dr. Eric Feigl-Ding appraises RFK Jr's embarrassing testimony to Congress. Also Epstein's 50th birthday book: who is in it and what did they say? It has a distressing central meme of seemingly abusing young girls. Good News Alert! New Mexico will become the first state to offer free universal childcare, setting a model for all. Poland shoots down Russian drones in its airspace. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Many Americans who want to get the newest COVID vaccines may now have a harder time doing so. The Food and Drug Administration limited approval for the shots to adults 65 and older or those who are "high risk" for severe disease. The vaccine was previously available to individuals six months of age and older. Amna Nawaz discussed the changes with Dr. Katelyn Jetelina of Your Local Epidemiologist. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Many Americans who want to get the newest COVID vaccines may now have a harder time doing so. The Food and Drug Administration limited approval for the shots to adults 65 and older or those who are "high risk" for severe disease. The vaccine was previously available to individuals six months of age and older. Amna Nawaz discussed the changes with Dr. Katelyn Jetelina of Your Local Epidemiologist. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Swedens state epidemiologist Magnus Gisslén has resigned, criticising the leadership of the Public Health Agency. Also this week: Swedish Radio's foreign correspondents gathered in Stockholm to share insights from around the world, we speak to three of them, covering U.S. politics and life in war-torn Ukraine and the Middle East.Presenters: Babak Parham & Michael Walsh.

A round-up of the main headlines in Sweden on August 19th, 2025. You can hear more reports on our homepage www.radiosweden.se, or in the app Sveriges Radio. Presenter/Producer: Kris Boswell

About this episode: Fall vaccines for flu, RSV, and—more recently—COVID have long followed a uniform rollout schedule allowing clinics and pharmacies ample time to order and administer shots. But that process looks different this year, raising concerns about access. In this episode: Katelyn Jetelina, publisher of Your Local Epidemiologist, explains how changes to the CDC's Advisory Committee on Immunization Practices (ACIP) and the FDA are pushing back the timeline and changing recommendations for routine vaccinations. Guest: Katelyn Jetelina, PhD, MPH, is an epidemiologist and scientific communicator. She is the co-founder of Health Trust Initiative, an adjunct professor at Yale School of Public Health, and a Senior Scientific Advisor to several government and non-profit agencies, including the CDC. In addition, Jetelina is the publisher of Your Local Epidemiologist. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: What's the plan for fall vaccines? If you're confused, you're not alone—Your Local Epidemiologist Covid cases rising in US as officials plan to restrict booster vaccines—The Guardian Will New Vaccine Recommendations Affect Your Fall Flu Shot?—AARP Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

NPR's Steve Inskeep talks with epidemiologist Michael Osterholm about a Trump administration decision to end funding for research into vaccines that fight respiratory viruses like COVID-19 and the flu.Support NPR and hear every episode of Trump's Terms sponsor-free with NPR+. Sign up at plus.npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

A leading addiction expert explains how he's driven by the memory of a friend who died, and why he believes giving data on the drug supply to people on the street is more important than using it to inform national drug policy.Guest:Nabarun Dasgupta, Epidemiologist, University of North Carolina Street Drug Analysis Lab and Opioid Data LabLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Dr. Katelyn Jetelina, epidemiologist and CEO of Your Local Epidemiologist, shares how her public health newsletter helps to educate readers about the policies and science impacting public health today; Tracy Gruber, Executive Director of the Utah Department of Health and Human Services, explains how the state's new behavioral health commission works to connect its fragmented mental health infrastructure; ASTHO will host a webinar on Wednesday, July 30th, to teach participants how to navigate the new suicide prevention infrastructure legal maps; and a new ASTHO resource can help jurisdictions promote public health and avoid adverse childhood experiences by prioritizing economic support policies.  Your Local Epidemiologist Utah Behavioral Health Master Plan ASTHO Webinar: State and Territorial Infrastructure for Suicide Prevention: Exploring New Legal Maps ASTHO Web Page: Prioritizing Economic Support Policies to Prevent ACEs and Promote Public Health  

Howie and Harlan are joined by public health communicator Katelyn Jetelina for updates on COVID-19 and other issues, and to discuss how her emails to students and colleagues in the early days of the pandemic turned into a platform with global reach. Harlan looks at how AI is being used on both sides of the battle between providers and insurers over claims; Howie reports on a setback with a promising gene therapy for Duchenne muscular dystrophy. Links: Insurance Claims, AI, and Wearables “Elevance Health Reports Second Quarter 2025 Results” “Elevance lowers profit outlook, warns things will get worse for health insurers ““Blue KC wrongfully denied medical diagnoses, hospital alleges in AI-driven claims lawsuit” “Oscar Health cuts full-year guidance, estimates 2025 loss as ACA marketplace stumbles” Whoop “WHOOP Delivers Innovative Blood Pressure Insights for a Deeper Look at Your Well-Being” “Introducing Heart Screener: A smarter way to stay connected to your heart health” “Whoop says FDA is ‘overstepping its authority' with warning about blood pressure feature” FDA: WARNING LETTER, WHOOP, Inc. “RFK Jr. wants everyone to use wearables. What are the benefits, risks?” “Apple to Sell Watches With Blood-Oxygen Feature Disabled After Legal Setback” Your Local Epidemiologist Your Local Epidemiologist “Poll: Trust in Public Health Agencies and Vaccines Falls Amid Republican Skepticism” “Popular epidemiologist lays out future path of public health communication” Yale School of Public Health: PopHIVE Katelyn Jetelina: “NIH: The quiet engine of science is being dismantled” Katelyn Jetelina: “Covid-19 in pockets, sugar cane isn't better, ticks march on, rescission cuts (vs. everything else), bright spots, and more” Mayo Clinic: Norovirus infection Katelyn Jetelina: “The show must go on...” Katelyn Jetelina: “Harassment against scientists is out of control” Katelyn Jetelina: “Medicaid cuts: The how and why” CDC: H5 Bird Flu: Current Situatio CDC: Current Epidemic Trends (Based on Rt) for States” CDC: Measles Cases and Outbreaks Treating Duchenne Muscular Dystrophy Cleveland Clinic: Duchenne Muscular Dystrophy (DMD) “FDA approves Sarepta's Duchenne gene therapy for nearly all patients” “AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial” “Patient dies in Sarepta gene therapy trial, adding to safety concerns” “FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths” “In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy” “Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Send us a textGreat conversation with the one and only Dr. Katelyn Jetelina, AKA Your Local Epidemiologist, about the power of showing up, the experience with members of the Make America Healthy Again movement on the Why Should I Trust You podcast, the work of distinguishing public health from the industrial complexes of food and pharma and insurance and also acknowledging that the status quo of public health needs to change and taking that first step no matter how small because it matters.  Such a rich conversation and we were so honored to have her!Dr. Katelyn Jetelina is an epidemiologist and scientific communicator. She is the co-founder of the non-profit Health Trust Initiative, an adjunct professor at Yale School of Public Health, and former Senior Scientific Advisor to the White House and Centers for Disease Control and Prevention. In addition, Dr. Jetelina is the publisher of Your Local Epidemiologist- a public health newsletter that “translates” ever-evolving science to the public, reaching over 500 million views in over 133 countries. Dr. Jetelina has received numerous national awards, including recently being named a TIME100 Most Influential Person in Health. Check out her newsletter https://yourlocalepidemiologist.substack.com/p/what-would-making-america-healthyCheck out our YouTube Channel https://www.youtube.com/@helpmakeitmakesense6769/aboutSend us your questions and comments to drtonianddraimee@gmail.comThanks to Jeff Jeudy for our themesong!

Jessica Malaty Rivera is an infectious disease epidemiologist and science communicator renowned for making complex public health information accessible, particularly during the COVID-19 pandemic. While initially premed at USC, she pivoted to studying health promotion and disease prevention, and worked in the nonprofit sector after college. She was later recruited to research emerging biological threats at Georgetown University and simultaneously decided to pursue a master's degree there in biohazardous threat agents and emerging infectious diseases. While she's always loved science, she began to realize that where she truly excelled was in “speaking science.” And the deeper Rivera got into infectious disease epidemiology—whether through work or academia—the more she realized how critical the communications aspect of science was to public health. When the COVID-19 pandemic hit, she joined The Atlantic to lend her expertise to the COVID Tracking Project to provide publicly available, comprehensive data on COVID-19 cases in real time. She then began using Instagram to explain and interpret global health news, unexpectedly gaining a large following for her easy-to-understand information. Over the past five years, she has grown her platform, launched a Substack, and is currently completing a Doctorate in Public Health from Johns Hopkins University, all while remaining dedicated to science facts and public health literacy.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Go to https://stewpeters.petclub247.com/ for natural goodness and immume support to your pets. Jaymie Icke joins Stew from the UK to speak out about fake puppet regimes, depopulation agenda, white replacement, and more! Nicolas Huschler, Epidemiologist at The McCullough Foundation joins Stew to discuss the continuing War on Fertility, including a shocking new study that revealed that the Covid shots DESTROY over 60% of women's egg supply! Kurt and Cristin Ludlow of PetClub 247 joins Stew to discuss the War on Pets in America, and how they are being poisoned and killed via their toxic food and product supply!

「 SUPPORT OUR SPONSORS 」 Find out more about the brands that make this show possible and get special discounts on Dr. Drew's favorite products at ⁠⁠https://drdrew.com/sponsors⁠⁠  • ACTIVE SKIN REPAIR - Repair skin faster with more of the molecule your body creates naturally! Hypochlorous (HOCl) is produced by white blood cells to support healing – and no sting. Get 20% off at ⁠⁠https://drdrew.com/skinrepair⁠⁠ • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠https://drdrew.com/fatty15⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠https://drdrew.com/paleovalley⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠https://twc.health/drew⁠⁠ 「 MEDICAL NOTE 」 Portions of this program may examine countervailing views on important medical issues. Always consult your physician before making any decisions about your health. 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (⁠⁠https://kalebnation.com⁠⁠) and Susan Pinsky (⁠⁠https://twitter.com/firstladyoflov⁠⁠⁠⁠e⁠⁠). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Learn more about your ad choices. Visit megaphone.fm/adchoices

To celebrate the confirmation of Jay Bhattacharya as director of the NIH, this week's “Kibbe on Liberty” features unseen footage from Matt Kibbe's series “The Coverup,” in which Dr. Bhattacharya explains how he was demonized and attacked for his opposition to COVID lockdowns, as well as some greatest hits from Jay's previous appearances on the show.

Have you been thinking about weaning your baby or toddler and you have NO clue how to start? Daytime or nighttime first? What if they cry for it? How long will it take? All of these questions and MORE answered in today's episode with Rachael and "Weaning Pal" Candace St. John, MPH, CLC. This week, Rachael and Candace emphasize the need to normalize extended breastfeeding and dive into the emotional aspects of the weaning process (both for parent and baby!), as well as discuss the complexities of weaning from breastfeeding- addressing common concerns such as guilt, attachment, sleep associations, and the right age to wean. Here's what you'll hear inside this informative episode: Candace's Journey into Weaning Expertise Rach and Candace's Personal Weaning Experiences and Strategies Navigating Boundaries or "Loving Limits" While Weaning Understanding Nursing Aversions and Their Impact Navigating Weaning Guilt Is there a "Right" Age for Weaning? Managing Weaning-Related Depression Addressing Picky Eating During Weaning Alternatives to Cow's Milk Distinguishing Between Comfort and Hunger Needs + so much more! About Candace: I'm a public health professional (MPH), pediatric sleep specialist, & Certified Lactation Counselor (CLC, #34044) — but most importantly, I am a mom of one weanling! I hold a Master of Public Health from Boston University School of Public Health & worked as an Epidemiologist for 5.5 years in a rural hospital setting. After becoming a mom (& having the most tumultuous start to breastfeeding my baby), I realized that there are many gaps in parenting education & practice. Now, I provide evidence-informed guidance & support to parents in order to feel confident at the end of their breastfeeding journey! You can connect with Candace and get support on your journey on Instagram @yourweaningpal Rachael is a mom of 3, founder of Hey, Sleepy Baby, and the host of this podcast. Instagram | Tiktok |  Website  ✨For sleep support and resources, visit heysleepybaby.com and follow @heysleepybaby on Instagram!

Cardiologist & Epidemiologist, Peter A. McCullough, MD, joins Del with a shocking study linking the origins of the current clade of H1N5 dominating the news cycle and crushing the egg industry can be tracked back to a USDA poultry research lab in Georgia.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

The Trump administration plans to roll out a new strategy against the bird flu. There are few details, but to bring egg prices down, the plan is aimed at trying to minimize the slaughter of chickens when the flu strikes a flock. More than 150 million poultry have been affected since 2022 and 58 people have been sickened by it. Geoff Bennett discussed more with epidemiologist Dr. Katelyn Jetelina. PBS News is supported by - https://www.pbs.org/newshour/about/funders